U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
130831130831Project CASA: Promoting Smoke-Free Indoor Air Policy in Mexican American HouseholdsRecruitingNo Results AvailableCancerBehavioral: Printed Materials|Behavioral: Fotonovelashttps://ClinicalTrials.gov/show/NCT00850954
130832130832Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomyRecruitingNo Results AvailableProstate CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00850941
130833130833Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloidsActive, not recruitingNo Results AvailablePostoperative Cognitive Dysfunction|Mild Cognitive Impairmenthttps://ClinicalTrials.gov/show/NCT00850928
130834130834Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in KenyaCompletedNo Results AvailableTuberculosisOther: community IPThttps://ClinicalTrials.gov/show/NCT00850915
130835130835Humidity Strategy to Decrease Morbidity and Mortality in Extremely Low Birth Weight InfantsNot yet recruitingNo Results AvailableExtremely Low Birth WeightOther: High Humidity (HH)|Other: Moderate Humidityhttps://ClinicalTrials.gov/show/NCT00850902
130836130836Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial FoldsCompletedHas ResultsNasolabial FoldsDevice: Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine|Device: A gel of hyaluronic acid (concentration of 20 mg/mL)https://ClinicalTrials.gov/show/NCT00850889
130837130837Heated Humidified Continuous Positive Airway Pressure and Nasal PhysiologyCompletedNo Results AvailableObstructive Sleep Apnea Syndrome|Nasal Obstructionhttps://ClinicalTrials.gov/show/NCT00850876
130838130838Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)RecruitingNo Results AvailableChronic Obstructive Pulmonary Diseasehttps://ClinicalTrials.gov/show/NCT00850863
130839130839Physostigmine After General AnesthesiaRecruitingNo Results AvailablePostoperative Nausea and Vomiting|Anesthesia Recovery PeriodDrug: physostigmine|Drug: Isotonic sodium chloride solutionhttps://ClinicalTrials.gov/show/NCT00850850
130840130840Safety of Acidform Lubricant in HIV-Uninfected WomenCompletedNo Results AvailableHIV InfectionsDrug: Acidform Lubricant|Drug: HEC gelhttps://ClinicalTrials.gov/show/NCT00850837
130841130841Community Health Workers in Diabetes Care in American SamoaEnrolling by invitationNo Results AvailableType 2 Diabetes MellitusBehavioral: Community Health Worker home visitshttps://ClinicalTrials.gov/show/NCT00850824
130842130842A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNo Results AvailableActinic KeratosisDrug: PEP005 (ingenol mebutate) Gelhttps://ClinicalTrials.gov/show/NCT00850811
130843130843The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 DiabetesRecruitingNo Results AvailableType 2 DiabetesDrug: Intensive glycemic control|Drug: Conservative glycemic controlhttps://ClinicalTrials.gov/show/NCT00850798
130844130844Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon Small Cell Lung CancerBiological: DRibble vaccinehttps://ClinicalTrials.gov/show/NCT00850785
130845130845Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian CancerCompletedNo Results AvailableEpithelial Ovarian Cancer|Peritoneal Cancer|Fallopian Tube CancerDietary Supplement: Early post-operative enteral feedinghttps://ClinicalTrials.gov/show/NCT00850772
130846130846Using Virtual Reality to Train Children in Pedestrian SafetyCompletedHas ResultsStreet-crossing Ability|Pedestrian SafetyDevice: virtual pedestrian environment|Device: computer and video|Behavioral: streetside traininghttps://ClinicalTrials.gov/show/NCT00850759
130847130847A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy AdultsCompletedNo Results AvailableFunctional DyspepsiaDrug: YM443|Drug: Placebo|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT00850746
130848130848516-BOTOX Urinary Incontinence DetrusorCompletedNo Results AvailableUrinary Incontinence|Urinary Bladder, Overactivehttps://ClinicalTrials.gov/show/NCT00850733
130849130849Study of Possible Brain Hormone Problems After Open Heart Surgery in InfantsTerminatedHas ResultsCongenital Heart DiseaseOther: Blood drawshttps://ClinicalTrials.gov/show/NCT00850720
130850130850Vascular Access for Hemodialysis and InflammationCompletedNo Results AvailableVascular Access for Hemodialysis and Inflammationhttps://ClinicalTrials.gov/show/NCT00850707
130851130851Vitamin D Deficiency in Obese Adolescent Girls and Influence of Vitamin D on Insulin Secretion and SensitivityCompletedNo Results AvailableVitamin D Deficiency|Obesity|Insulin Resistancehttps://ClinicalTrials.gov/show/NCT00850694
130852130852A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNo Results AvailableActinic KeratosisDrug: PEP005 (ingenol mebutate) Gelhttps://ClinicalTrials.gov/show/NCT00850681
130853130853Peanut Allergy Vaccine Study in Healthy and Peanut-allergic AdultsCompletedNo Results AvailableFood Hypersensitivity|Hypersensitivity|Immediate Hypersensitivity|Peanut HypersensitivityBiological: E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3https://ClinicalTrials.gov/show/NCT00850668
130854130854Genetic Association Mapping of Malaria Resistance in Anopheles GambiaeActive, not recruitingNo Results AvailableMalariahttps://ClinicalTrials.gov/show/NCT00850655
130855130855GSK2190915 Moderate to Severe Asthma StudyTerminatedNo Results AvailableAsthmaDrug: GSK2190195 100mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00850642
130856130856Hormonal Regulation of Body Weight MaintenanceActive, not recruitingNo Results AvailableWeight RegainBehavioral: multimodal lifestyle intervention|Behavioral: placebohttps://ClinicalTrials.gov/show/NCT00850629
130857130857Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)CompletedNo Results AvailableHIV|HIV InfectionsBiological: V526|Biological: Comparator: Placebo to V526https://ClinicalTrials.gov/show/NCT00850616
130858130858Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®CompletedHas ResultsMeningococcal Infections|MeningitisBiological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined|Biological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined|Biological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined|Biological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined|Biological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combinedhttps://ClinicalTrials.gov/show/NCT00850603
130859130859Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different WeightsCompletedNo Results AvailableIncontinenceDrug: NRL001https://ClinicalTrials.gov/show/NCT00850590
130860130860Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerTerminatedNo Results AvailableNon-small Cell Lung Cancer (NSCLC)Drug: Paclitaxel|Drug: Carboplatin|Drug: CT-322|Drug: Bevacizumab|Drug: Bevacizumab placebo (ie saline solution)https://ClinicalTrials.gov/show/NCT00850577

* Görseller ve İçerik tekif hakkına sahip olabilir